These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 6602846

  • 1. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ, Muraguchi A, Hong JX, Butler JL, Dinarello CA, Fauci AS.
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [Abstract] [Full Text] [Related]

  • 2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S, Giudizi GM, Maggi E, Almerigogna F, Biagiotti R, Del Prete G, Mazzetti M, Alessi A, Vercelli D, Ricci M.
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [Abstract] [Full Text] [Related]

  • 3. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S, Giudizi MG, Biagiotti R, Almerigogna F, Maggi E, Del Prete G, Ricci M.
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [Abstract] [Full Text] [Related]

  • 4. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T, Vanbervliet B, Aubry JP, Takebe Y, Arai N, Miyajima A, Yokota T, Lee F, Arai K, de Vries JE.
    J Immunol; 1987 Aug 15; 139(4):1135-41. PubMed ID: 3112225
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M.
    Eur J Immunol; 1986 Jun 15; 16(6):623-9. PubMed ID: 3087756
    [Abstract] [Full Text] [Related]

  • 6. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF, Lipsky PE.
    J Immunol; 1987 Aug 15; 139(4):1005-13. PubMed ID: 3112218
    [Abstract] [Full Text] [Related]

  • 7. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH, Muraguchi A, Fauci AS.
    Eur J Immunol; 1984 Feb 15; 14(2):115-21. PubMed ID: 6199210
    [Abstract] [Full Text] [Related]

  • 8. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT, Springgate CF, Piela TH, Choi YS.
    J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160
    [Abstract] [Full Text] [Related]

  • 9. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
    Thompson CB, Schaefer ME, Finkelman FD, Scher I, Farrar J, Mond JJ.
    J Immunol; 1985 Jan 15; 134(1):369-74. PubMed ID: 3917279
    [Abstract] [Full Text] [Related]

  • 10. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL, Chesky L, Stephany D, McFarland P, Mostowski H, Fauci AS.
    J Immunol; 1990 Dec 15; 145(12):3949-55. PubMed ID: 2258603
    [Abstract] [Full Text] [Related]

  • 11. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S, Taguchi M, Watanabe Y, Okubo T, Murachi T, Uchino H, Hanaoka M.
    J Immunol; 1984 Dec 15; 133(6):3084-90. PubMed ID: 6238094
    [Abstract] [Full Text] [Related]

  • 12. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T, Butler JL, Cooper MD.
    J Immunol; 1985 Apr 15; 134(4):2470-6. PubMed ID: 2982946
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T, Nakagawa N, Ambrus JL, Fauci AS.
    J Immunol; 1988 Jan 15; 140(2):465-9. PubMed ID: 2447179
    [Abstract] [Full Text] [Related]

  • 14. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A, Auffredou MT, Gerard JP, Delfraissy JF, Galanaud P.
    J Immunol; 1987 Oct 01; 139(7):2344-8. PubMed ID: 3116080
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L, Delfraissy JF, Vazquez A, Wallon C, Galanaud P, Kazatchkine MD.
    J Immunol; 1987 May 01; 138(9):2988-93. PubMed ID: 2952731
    [Abstract] [Full Text] [Related]

  • 16. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR, Subbarao B.
    J Mol Cell Immunol; 1988 May 01; 4(1):45-57. PubMed ID: 3266924
    [Abstract] [Full Text] [Related]

  • 17. Functional properties of two human B cell growth factor species separated by lectin affinity column.
    Dugas B, Vazquez A, Geŕard JP, Richard Y, Auffredou MT, Delfraissy JF, Fradelizi D, Galanaud P.
    J Immunol; 1985 Jul 01; 135(1):333-8. PubMed ID: 3923105
    [Abstract] [Full Text] [Related]

  • 18. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A, Gérard JP, Olive D, Auffredou MT, Dugas B, Karray S, Delfraissy JF, Galanaud P.
    Eur J Immunol; 1986 Dec 01; 16(12):1503-7. PubMed ID: 3102243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A, Kehrl JH, Butler JL, Fauci AS.
    J Immunol; 1984 Jan 01; 132(1):176-80. PubMed ID: 6197443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.